Procaps Group, S.A Shares Outstanding 2020-2023 | PROCF
Procaps Group, S.A shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Procaps Group, S.A Annual Shares Outstanding
(Millions of Shares) |
| 2022 |
101 |
| 2021 |
98 |
| 2020 |
97 |
| 2020 |
5 |
| 2019 |
97 |
| 2019 |
4 |
| 2018 |
|
Procaps Group, S.A Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-09-30 |
101 |
| 2023-06-30 |
101 |
| 2023-03-31 |
101 |
| 2022-12-31 |
101 |
| 2022-09-30 |
101 |
| 2022-06-30 |
101 |
| 2022-03-31 |
101 |
| 2021-12-31 |
98 |
| 2021-09-30 |
97 |
| 2021-06-30 |
97 |
| 2021-03-31 |
97 |
| 2020-12-31 |
5 |
| 2020-09-30 |
|
| 2020-06-30 |
5 |
| 2020-03-31 |
5 |
| 2019-12-31 |
5 |
| 2019-09-30 |
|
| 2019-06-30 |
4 |
| 2019-03-31 |
4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
